Dorsal Augmentation Rhinoplasty by Cartilage Allograft
Harutyunyan A., Hakobyan G.
Prospective Study with a reported sample of 104, published in J Cosmet Dermatol (2025) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- J Cosmet Dermatol (2025)
- Reported sample size
- 104
- Source database
- Europe PMC
- PMID
- 39666565
- PMCID
- PMC11845963
- DOI
- 10.1111/jocd.16724
- Citations
- 1
Abstract (original English)
Background The aim of this study was to evaluate long-term outcomes and patient satisfaction after nasal dorsal rhinoplasty with allogeneic cartilage graft of the nasal septum. Materials and methods The present study included 104 patients (41 males and 63 females) whose mean age at surgery was 28.7 years and who underwent nasal dorsal augmentation with allogenous nasal septal cartilage graft during the period 2017-2023. Depending on the use of platelet-rich fibrin (PRF), the patients were divided into two groups: Group I had PRF applied in dorsal rhinoplasty and included 53 patients (29 males and 24 females). Group II (control group) had dorsal rhinoplasty without the use of PRF and included 51 patients (26 males and 25 females). Donor patients included those who had taken excess nasal septal cartilage during functional rhinoplasty. According to the indications, crushed allogenic septal cartilage graft and PRF were also used. Esthetic results of rhinoplasty were assessed from preoperative and postoperative clinical pictures and also by visual examination. To assess the results of esthetic rhinoplasty, the Portuguese version of the Utrecht Questionnaire (UQ) was used, which contains a visual analog scale (VAS) on a 5-point Likert scale. Results In patients included in the study, there were no serious complications: there was no deformation or extrusion, and allograft resorption
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.